Respiratory Drugs Market Players:
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Alcon, Inc.
- Collegium Pharmaceutical Inc.
- Merck & Co. Inc.
- GlaxoSmithKline plc
- Verona Pharma Plc
- Teva Pharmaceuticals
- Sandoz Inc.
- Hospira Inc.
- Novacyt Group
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of respiratory drugs is assessed at USD 19.42 billion.
The global respiratory drugs market size was valued at over USD 18.38 billion in 2025 and is expected to register a CAGR of more than 6.3%, exceeding USD 33.86 billion revenue by 2035.
North America respiratory drugs market will hold more than 35% share by 2035, driven by rising respiratory diseases and obesity rates in the region.
Key players in the market include of GlaxoSmithKline plc, Verona Pharma Plc, Teva Pharmaceuticals, Sandoz Inc., Hospira Inc., Novacyt Group.
